This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology
Legal and regulatory update
Go to paperABSTRACT: The Office of Fair Trading (OFT) has recently found Genzyme Limited guilty of abusing its dominant posi…
Make in India recently published an advertorial in the Washington Post proclaiming that “2016 is India’s Growth Year For Pharma.” I don’t doubt that India has growth potential, as it ranks 51st out of 54 nations that I compare in the Scientific American Worldview scorecard. The problem with Make in India’s encouraging proclamation is that […]